Evidence map›Paper›PMID 35624123›Full record

ArticleNature communications2022

Transmission of SARS-CoV-2 from humans to animals and potential host adaptation.

Cedric C S Tan, Su Datt Lam, Damien Richard, Christopher J Owen, Dorothea Berchtold, Christine Orengo, Meera Surendran Nair, Suresh V Kuchipudi, Vivek Kapur, Lucy van Dorp and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Cedric C S TanUCL Genetics Institute, University College London, London, UK. cedriccstan@gmail.com.ORCID http://orcid.org/0000-0003-3536-8465
Su Datt LamDepartment of Applied Physics, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi, Selangor, Malaysia.
Damien RichardUCL Genetics Institute, University College London, London, UK.
Christopher J OwenUCL Genetics Institute, University College London, London, UK.ORCID http://orcid.org/0000-0002-5991-1533
Dorothea BerchtoldUCL Genetics Institute, University College London, London, UK.
Christine OrengoDepartment of Structural and Molecular Biology, University College London, London, UK.ORCID http://orcid.org/0000-0002-7141-8936
Meera Surendran NairAnimal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, PA, Pennsylvania, USA.
Suresh V KuchipudiAnimal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, PA, Pennsylvania, USA.ORCID http://orcid.org/0000-0002-8640-254X
Vivek KapurHuck Institutes of the Life Sciences, The Pennsylvania State University, PA, Pennsylvania, USA.
Lucy van DorpUCL Genetics Institute, University College London, London, UK.ORCID http://orcid.org/0000-0002-6211-2310
François BallouxUCL Genetics Institute, University College London, London, UK.ORCID http://orcid.org/0000-0003-1978-7715
University College London · GBPennsylvania State University · USInstitute of Structural and Molecular Biology · GBUK Dementia Research Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/R01356X/1Department of Health
6 · The paper itself

Abstract

SARS-CoV-2, the causative agent of the COVID-19 pandemic, can infect a wide range of mammals. Since its spread in humans, secondary host jumps of SARS-CoV-2 from humans to multiple domestic and wild populations of mammals have been documented. Understanding the extent of adaptation to these animal hosts is critical for assessing the threat that the spillback of animal-adapted SARS-CoV-2 into humans poses. We compare the genomic landscapes of SARS-CoV-2 isolated from animal species to that in humans, profiling the mutational biases indicative of potentially different selective pressures in animals. We focus on viral genomes isolated from mink (Neovison vison) and white-tailed deer (Odocoileus virginianus) for which multiple independent outbreaks driven by onward animal-to-animal transmission have been reported. We identify five candidate mutations for animal-specific adaptation in mink (NSP9_G37E, Spike_F486L, Spike_N501T, Spike_Y453F, ORF3a_L219V), and one in deer (NSP3a_L1035F), though they appear to confer a minimal advantage for human-to-human transmission. No considerable changes to the mutation rate or evolutionary trajectory of SARS-CoV-2 has resulted from circulation in mink and deer thus far. Our findings suggest that minimal adaptation was required for onward transmission in mink and deer following human-to-animal spillover, highlighting the 'generalist' nature of SARS-CoV-2 as a mammalian pathogen.

Indexed as

COVID-19DeerAnimalsHost AdaptationHumansPandemicsSARS-CoV-2

Identifiers

PMID35624123
PMCPMC9142586
OpenAlexW4281741329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.